Endonovo Therapeutics Announces Steven Ford as V.P. Marketing
May 07, 2019 09:20 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, May 07, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, Steven Ford will be joining the company as Vice President of Marketing. In his position,...
Endonovo Therapeutics Announces Partnership with Second Hospital
March 29, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA , March 29, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announced an agreement with a nationally recognized hospital group...
Endonovo Therapeutics Granted Trademarks for WoundPulse and OrthoHalo
March 22, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, March 22, 2019 (GLOBE NEWSWIRE) -- March 22, 2019 -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Endonovo Therapeutics Partners with SunMED Medical Systems
March 20, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, March 20, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), Alan Collier, Endonovo’s Chief Executive Officer, stated "We are...
Endonovo Therapeutics Issues Shareholder Letter and Update
January 11, 2019 09:15 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Enters into $10 million Common Stock Purchase Agreement with Azure Capital
January 03, 2019 11:10 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
December 18, 2018 09:25 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies...
Endonovo Therapeutics Announces Complimentary New Product
November 08, 2018 10:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...
Endonovo Therapeutics Provides Update on Liver Study
October 22, 2018 10:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...
Endonovo Therapeutics Signs Distribution Agreement For National Distribution of Sofpulse® Electroceutical™ System
August 14, 2018 09:25 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of Electroceutical™ Therapies, today...